- Home
- Proton Therapy Market
Global Proton Therapy Market - Industry Trends and Forecast to 2028
- Published Date: September, 2022 | Report ID: CLS-266 | No of pages: 332 | Format:
Global proton therapy market is projected to register a CAGR of 6.5% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028
Market Segmentation:
Global Proton Therapy Market, By Product Type (Systems, Software, Services), Component (Proton Accelerator, Beam Transport System, Beam Delivery System, Nozzle, Image Viewers, Patient Positioning System (PPS)), Type (Rotating Proton Therapy Systems, Non Rotating Proton Therapy Systems), Set-Up Systems (Multi-Room Systems, Compact/ Single-Room Systems), Application Type (Treatment Applications, Research Applications), End User (Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Some of the major factors contributing to the growth of the global proton therapy market are:
Increase healthcare expenditure in the developing countries
Growing demand of proton therapy in the region
Market Players:
The key market players for global proton therapy market are listed below:
Varian Medical Systems, Inc.
Protom International
Mevion Medical Systems
Sun Nuclear Corporation
Provision Healthcare
Hitachi, Ltd.
Sumitomo Heavy Industries, Ltd.
Koninklijke Philips N.V.
IBA Worldwide
Elekta AB
Optivus Proton Therapy, Inc.
Advanced Oncotherapy
GE Healthcare (A subsidiary of General Electric Company)
Best Cyclotron Systems, Inc.
RaySearch Laboratories
PerMedics, Inc
TABLE OF CONTENT
TABLE OF CONTENTS 1 INTRODUCTION 36 1.1 OBJECTIVES OF THE STUDY 36 1.2 MARKET DEFINITION 36 1.3 OVERVIEW OF GLOBAL PROTON THERAPY MARKET 36 1.4 CURRENCY AND PRICING 38 1.5 LIMITATIONS 38 1.6 MARKETS COVERED 39 2 MARKET SEGMENTATION 43 2.1 MARKETS COVERED 43 2.2 GEOGRAPHICAL SCOPE 44 2.3 YEARS CONSIDERED FOR THE STUDY 45 2.4 DBMR TRIPOD DATA VALIDATION MODEL 46 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 49 2.6 MULTIVARIATE MODELLING 50 2.7 PRODUCT TYPE LIFELINE CURVE 51 2.8 DBMR MARKET POSITION GRID 52 2.9 VENDOR SHARE ANALYSIS 54 2.10 MARKET APPLICATION TYPE COVERAGE GRID 55 2.11 SECONDARY SOURCES 56 2.12 ASSUMPTIONS 56 3 EXECUTIVE SUMMARY 57 4 PREMIUM INSIGHT 61 5 GLOBAL PROTON THERAPY MARKET: REGULATIONS 63 6 MARKET OVERVIEW 65 6.1 DRIVERS 67 6.1.1 RISING NUMBER OF PROTON THERAPY CENTERS 67 6.1.2 INCREASING PREVALENCE OF CANCER 68 6.1.3 ADVANTAGES OFFERED BY THE PROTON THERAPY TREATMENT IN CANCER 70 6.1.4 INCREASING FUNDING FOR CANCER RESEARCH 70 6.1.5 HIGHER AGING POPULATION 71 6.2 RESTRAINTS 73 6.2.1 HIGH COST OF INSTALLATION OF INSTRUMENT 73 6.2.2 LACK OF REIMBURSEMENT 73 6.3 OPPORTUNITIES 74 6.3.1 GROWING RECOGNITION OF PROTON THERAPY 74 6.3.2 INCREASING HEALTHCARE EXPENDITURE 74 6.3.3 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 75 6.3.4 INTRODUCTION OF PROTON THERAPY IN EMERGING ECONOMIES 76 6.4 CHALLENGES 78 6.4.1 EXPENSIVE TREATMENT AS COMPARED TO OTHER TECHNOLOGIES 78 6.4.2 REQUIREMENT OF LARGE SPACE 78 7 COVID-19 IMPACT ON GLOBAL PROTON THERAPY MARKET 79 7.1 PRICE IMPACT 79 7.2 IMPACT ON SUPPLY CHAIN 79 7.3 IMPACT ON DEMAND 80 7.4 STRATEGIC DECISIONS FOR MANUFACTURERS 80 7.5 CONCLUSION 81 8 GLOBAL PROTON THERAPY MARKET, BY PRODUCT TYPE 82 8.1 OVERVIEW 83 8.2 SYSTEMS 86 8.2.1 ACCELERATORS 86 8.2.1.1 CYCLOTRONS 87 8.2.1.2 SYNCHROTRONS 87 8.2.2 BEAM DELIVERY 87 8.2.2.1 PENCIL BEAM SCANNING 87 8.2.2.2 PASSIVE SCATTERING 87 8.2.2.3 UNIFORM SCANNING 87 8.2.3 MODULATORS 88 8.2.4 OTHERS 88 8.3 SOFTWARE 88 8.4 SERVICES 88 9 GLOBAL PROTON THERAPY MARKET, BY COMPONENT 90 9.1 OVERVIEW 91 9.2 PROTON ACCELERATOR 94 9.2.1 CYCLOTRONS 95 9.2.2 SYNCHROTRONS 95 9.2.3 SYNCHROCYCLOTRONS 95 9.2.4 LINACS 95 9.2.5 H-MINUS SYNCHROTRONS 95 9.2.6 SEPARATED SECTOR CYCLOTRONS 95 9.2.7 SUPER-CONDUCTING CYCLOTRONS 95 9.2.8 FAST CYCLING SYNCHROTRON 95 9.3 BEAM TRANSPORT SYSTEM 95 9.4 BEAM DELIVERY SYSTEM 97 9.4.1 THE PASSIVE SCATTERING TECHNIQUE 97 9.4.2 BEAM SCANNING 98 9.5 NOZZLE 99 9.5.1 PENCIL SCANNING NOZZLE 99 9.5.2 SINGLE SCATTERING 100 9.5.3 DOUBLE SCATTERING 100 9.5.4 UNIFORM SCANNING NOZZLE 100 9.6 IMAGE VIEWERS 100 9.7 PATIENT POSITIONING SYSTEM (PPS) 100 10 GLOBAL PROTON THERAPY MARKET, BY TYPE 102 10.1 OVERVIEW 103 10.2 ROTATING PROTON THERAPY SYSTEMS 106 10.3 NON ROTATING PROTON THERAPY SYSTEMS 106 11 GLOBAL PROTON THERAPY MARKET, BY SET-UP SYSTEMS 108 11.1 OVERVIEW 109 11.2 MULTI-ROOM SYSTEMS 112 11.3 COMPACT/ SINGLE-ROOM SYSTEMS 112 12 GLOBAL PROTON THERAPY MARKET, BY APPLICATION TYPE 114 12.1 OVERVIEW 115 12.2 TREATMENT APPLICATIONS 118 12.2.1 PEDIATRIC CANCER 120 12.2.2 TUMORS IN THE BASE OF THE SKULL 120 12.2.3 PROSTATE CANCER 120 12.2.4 HEAD & NECK CANCER 120 12.2.5 BREAST CANCER 120 12.2.6 LUNG CANCER 120 12.2.7 TUMORS AFFECTING SPINE 120 12.2.8 EYE MELANOMA 120 12.2.9 LYMPHOMA 120 12.2.10 PITUITARY GLAND TUMORS 120 12.2.11 OTHERS 120 12.3 RESEARCH APPLICATIONS 121 13 GLOBAL PROTON THERAPY MARKET, BY END USER 122 13.1 OVERVIEW 123 13.2 HOSPITALS 126 13.3 AMBULATORY SURGICAL CENTERS 126 13.4 CANCER RESEARCH INSTITUTES 128 14 GLOBAL PROTON THERAPY MARKET, BY GEOGRAPHY 129 14.1 OVERVIEW 130 14.2 NORTH AMERICA 135 14.2.1 U.S. 142 14.2.2 CANADA 146 14.2.3 MEXICO 150 14.3 EUROPE 154 14.3.1 U.K. 161 14.3.2 GERMANY 165 14.3.3 FRANCE 169 14.3.4 ITALY 173 14.3.5 SPAIN 177 14.3.6 RUSSIA 181 14.3.7 BELGIUM 185 14.3.8 TURKEY 189 14.3.9 NETHERLANDS 193 14.3.10 SWITZERLAND 197 14.3.11 REST OF EUROPE 201 14.4 ASIA-PACIFIC 202 14.4.1 JAPAN 209 14.4.2 CHINA 213 14.4.3 SOUTH KOREA 217 14.4.4 INDIA 221 14.4.5 AUSTRALIA 225 14.4.6 SINGAPORE 229 14.4.7 THAILAND 233 14.4.8 MALAYSIA 237 14.4.9 INDONESIA 241 14.4.10 PHILIPPINES 245 14.4.11 REST OF ASIA-PACIFIC 249 14.5 MIDDLE EAST & AFRICA 250 14.5.1 SOUTH AFRICA 257 14.5.2 SAUDI ARABIA 261 14.5.3 UAE 265 14.5.4 ISRAEL 269 14.5.5 EGYPT 273 14.5.6 REST OF MIDDLE EAST & AFRICA 277 14.6 SOUTH AMERICA 278 14.6.1 BRAZIL 285 14.6.2 ARGENTINA 289 14.6.3 REST OF SOUTH AMERICA 293 15 GLOBAL PROTON THERAPY MARKET: COMPANY LANDSCAPE 294 15.1 COMPANY SHARE ANALYSIS: GLOBAL 294 15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 295 15.3 COMPANY SHARE ANALYSIS: EUROPE 296 15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 297 16 SWOT 298 17 COMPANY PROFILE 299 17.1 IBA WORLDWIDE 299 17.1.1 COMPANY SNAPSHOT 299 17.1.2 REVENUE ANALYSIS 299 17.1.3 COMPANY SHARE ANALYSIS 300 17.1.4 PRODUCT PORTFOLIO 300 17.1.5 RECENT DEVELOPMENTS 300 17.2 HITACHI, LTD. 301 17.2.1 COMPANY SNAPSHOT 301 17.2.2 REVENUE ANALYSIS 301 17.2.3 COMPANY SHARE ANALYSIS 302 17.2.4 PRODUCT PORTFOLIO 302 17.2.5 RECENT DEVELOPMENT 302 17.3 ELEKTA AB 303 17.3.1 COMPANY SNAPSHOT 303 17.3.2 REVENUE ANALYSIS 303 17.3.3 COMPANY SHARE ANALYSIS 304 17.3.4 PRODUCT PORTFOLIO 304 17.3.5 RECENT DEVELOPMENT 304 17.4 VARIAN MEDICAL SYSTEMS, INC. 305 17.4.1 COMPANY SNAPSHOT 305 17.4.2 REVENUE ANALYSIS 305 17.4.3 COMPANY SHARE ANALYSIS 306 17.4.4 PRODUCT PORTFOLIO 306 17.4.5 RECENT DEVELOPMENTS 306 17.5 SUMITOMO HEAVY INDUSTRIES, LTD. 308 17.5.1 COMPANY SNAPSHOT 308 17.5.2 REVENUE ANALYSIS 308 17.5.3 PRODUCT PORTFOLIO 309 17.5.4 RECENT DEVELOPMENTS 309 17.6 GENERAL ELECTRIC COMPANY 310 17.6.1 COMPANY SNAPSHOT 310 17.6.2 REVENUE ANALYSIS 310 17.6.3 PRODUCT PORTFOLIO 311 17.6.4 RECENT DEVELOPMENTS 311 17.7 ADVANCED ONCOTHERAPY 312 17.7.1 COMPANY SNAPSHOT 312 17.7.2 PRODUCT PORTFOLIO 312 17.7.3 RECENT DEVELOPMENT 312 17.8 BEST CYCLOTRON SYSTEMS, INC. 313 17.8.1 COMPANY SNAPSHOT 313 17.8.2 PRODUCT PORTFOLIO 313 17.8.3 RECENT DEVELOPMENTS 313 17.9 KONINKLIJKE PHILIPS N.V. 315 17.9.1 COMPANY SNAPSHOT 315 17.9.2 REVENUE ANALYSIS 315 17.9.3 PRODUCT PORTFOLIO 316 17.9.4 RECENT DEVELOPMENTS 316 17.10 MEVION MEDICAL SYSTEMS 317 17.10.1 COMPANY SNAPSHOT 317 17.10.2 PRODUCT PORTFOLIO 317 17.10.3 RECENT DEVELOPMENTS 317 17.11 OPTIVUS PROTON THERAPY, INC. 319 17.11.1 COMPANY SNAPSHOT 319 17.11.2 PRODUCT PORTFOLIO 319 17.11.3 RECENT DEVELOPMENT 319 17.12 PERMEDICS, INC. 320 17.12.1 COMPANY SNAPSHOT 320 17.12.2 PRODUCT PORTFOLIO 320 17.12.3 RECENT DEVELOPMENT 320 17.13 PROTOM INTERNATIONAL 321 17.13.1 COMPANY SNAPSHOT 321 17.13.2 PRODUCT PORTFOLIO 321 17.13.3 RECENT DEVELOPMENTS 321 17.14 PROVISION HEALTHCARE 323 17.14.1 COMPANY SNAPSHOT 323 17.14.2 PRODUCT PORTFOLIO 323 17.14.3 RECENT DEVELOPMENTS 324 17.15 RAYSEARCH LABORATORIES 325 17.15.1 COMPANY SNAPSHOT 325 17.15.2 REVENUE ANALYSIS 325 17.15.3 PRODUCT PORTFOLIO 326 17.15.4 RECENT DEVELOPMENTS 326 17.16 SUN NUCLEAR CORPORATION 327 17.16.1 COMPANY SNAPSHOT 327 17.16.2 PRODUCT PORTFOLIO 327 17.16.3 RECENT DEVELOPMENTS 328 18 QUESTIONNAIRE 329 19 RELATED REPORTS 332Segmentation
Short Description Global Proton Therapy Market, By Product Type (Systems, Software, Services), Component (Proton Accelerator, Beam Transport System, Beam Delivery System, Nozzle, Image Viewers, Patient Positioning System (PPS)), Type (Rotating Proton Therapy Systems, Non Rotating Proton Therapy Systems), Set-Up Systems (Multi-Room Systems, Compact/ Single-Room Systems), Application Type (Treatment Applications, Research Applications), End User (Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028. Market Definition: The proton therapy is the most precise and accurate radiation therapy which utilizes the energy of proton particles for killing the cancerous cells or the desired cell at particular location. The major limitations of photon therapy or other particle therapy are overcome by the proton therapy. The advancement in technology has increased the adoption of proton therapy for the treatment of various cancers across globe. Market Segmentation: The proton therapy market is categorized into six notable segments which are based on the product type, component, type, set-up systems, application type and end user. On the basis of product type, the proton therapy market is segmented into systems, software and services On the basis of component, the proton therapy market is segmented into proton accelerator, beam transport system, beam delivery system, nozzle, image viewers and patient positioning system (PPS) On the basis of type, the proton therapy market is segmented into rotating proton therapy systems and non rotating proton therapy systems On the basis of set-up systems , the proton therapy market is segmented into multi-room systems and compact/ single-room systems On the basis of application type, the proton therapy market is segmented into treatment applications and research applications On the basis of end user, the proton therapy market is segmented into hospitals, ambulatory surgical centers and cancer research institutes Market Players The key market players for global proton therapy market are listed below: Varian Medical Systems, Inc. Protom International Mevion Medical Systems Sun Nuclear Corporation Provision Healthcare Hitachi, Ltd. Sumitomo Heavy Industries, Ltd. Koninklijke Philips N.V. IBA Worldwide Elekta AB Optivus Proton Therapy, Inc. Advanced Oncotherapy GE Healthcare (A subsidiary of General Electric Company) Best Cyclotron Systems, Inc. RaySearch Laboratories PerMedics, IncMethodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.